Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSGZ.L Regulatory News (SGZ)

  • There is currently no data for SGZ

Director/PDMR Shareholding

4 Jan 2018 11:05

RNS Number : 9744A
Scotgold Resources Ltd
04 January 2018
Ā 

Scotgold Resources Limited

4 January 2018

Ā 

Scotgold Resources Limited

Ā 

Director/PDMR Dealings

Ā 

Scotgold Resources Limited (AIM:SGZ) (the "Company" or "SGZ") advises that certain of the directors and a PDMR of the Company participated in the recently completed non-renounceable rights issue, at a price of £0.25 per new ordinary share, that was first announced on 13 November 2017 (the "Rights Issue"). The relevant director/PDMR participations and their resulting holdings in the Company are as follows:

Ā 

Richard Gray (Director and Chief Executive Officer)

Holding prior to Rights Issue: 52,043 ordinary shares in SGZ

Rights Issue entitlement: 34,695 new ordinary shares in SGZ

Rights Issue shortfall shares: 10,000 new ordinary shares in SGZ

Ā 

Following the Rights Issue, Mr Gray holds 96,738 ordinary shares in the Company, representing 0.36% (previously 0.33%) of the Company's issued share capital. In addition, Mr Gray now holds 8,939 options to acquire one share each at an exercise price of £0.40, expiring on 31 December 2019. Prior to the Rights Issue, Mr Gray held no options in the Company.

Ā 

Christopher Sangster (Non-Executive Director)

Holding prior to Rights Issue: 182,045 ordinary shares in SGZ

Rights Issue entitlement: 20,000 new ordinary shares in SGZ

Rights Issue shortfall shares: -

Ā 

Following the Rights Issue, Mr Sangster holds 202,045 ordinary shares in the Company, representing 0.76% (previously 1.14%) of the Company's issued share capital. In addition, Mr Sangster now holds 4,000 options to acquire one share each at an exercise price of £0.40, expiring on 31 December 2019. Prior to the Rights Issue, Mr Sangster held no options in the Company.

Ā 

David Swan (Chief Financial Officer - PDMR)

Holding prior to Rights Issue: 10,000 ordinary shares in SGZ

Rights Issue entitlement: 6,667 new ordinary shares in SGZ

Rights Issue shortfall shares: 3,333 new ordinary shares in SGZ

Ā 

Following the Rights Issue, Mr Swan holds 20,000 ordinary shares in the Company, representing 0.07% (previously 0.06%) of the Company's issued share capital. In addition, Mr Swan now holds 2,000 options to acquire one share each at an exercise price of £0.40, expiring on 31 December 2019. Prior to the Rights Issue, Mr Swan held no options in the Company.

Ā 

Nat le Roux's (Non-Executive Chairman) participation in and underwriting of the Rights Issue, and his resulting holding, was disclosed in the Company's announcement dated 21 December 2017.

Ā 

Ā 

For further information please contact:

Ā 

Scotgold Resources Limited Stockdale Securities Limited

Richard Gray Robert Finlay / Ed Thomas

Tel: +44 (0)1838 400 306 Tel: +44 (0)20 7601 6100

Ā 

Ā 

Capital Markets Consultants Smaller Company Capital Ltd

Simon Rothschild Rupert Williams

Tel +44 (0)7703 167 065 Tel: +44 (0)20 3651 2911

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
DSHLLFEILEISIIT
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - Scotgold Resources Limited
24th Nov 202310:09 amRNSAppointment of Administrators
22nd Nov 20237:00 amRNSPlanned Appointment of Administrators
8th Nov 20237:00 amRNSDirector Resignation
7th Nov 20238:00 amRNSPotential Administration Appointment
16th Oct 20237:00 amRNSUpdate On Financing Discussions
2nd Oct 202310:18 amRNSPotential Administration Appointment
29th Sep 20237:00 amRNSCorporate Update
19th Sep 20239:10 amRNSMining Review Update
11th Sep 20237:30 amRNSSuspension - Scotgold Resources Limited
11th Sep 20237:00 amRNSGeological review, mine plan and operations update
10th Jul 20237:00 amRNSProduction, Sales & Operations – Q2 2023 & H1 2023
14th Jun 20237:00 amRNSBoard Appointment
7th Jun 20237:00 amRNSInterim CEO Appointment
1st Jun 20237:00 amRNSOperational Update and Director Resignation
15th May 20237:00 amRNSSubscription and Open Offer GBP2 million raised
26th Apr 20237:00 amRNSPosting of Circular
21st Apr 20237:00 amRNSSubscription & Open Offer to raise £1.5-2.0m
5th Apr 20237:00 amRNSOfftake advance & commencement long hole stoping
31st Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20237:00 amRNSInterim Results
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20232:05 pmRNSSecond Price Monitoring Extn
27th Mar 20232:00 pmRNSPrice Monitoring Extension
27th Mar 202311:06 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
27th Mar 20239:05 amRNSSecond Price Monitoring Extn
27th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20237:00 amRNSOperations and Corporate Update
16th Feb 20237:00 amRNSResult of Retail Offer - Capital Raising of £3m
10th Feb 202311:05 amRNSSecond Price Monitoring Extn
10th Feb 202311:00 amRNSPrice Monitoring Extension
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
10th Feb 20237:00 amRNSResults of Capital Raise
9th Feb 20235:00 pmRNSRetail Offer
9th Feb 20234:42 pmRNSProposed Capital Raising
7th Feb 20239:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20239:05 amRNSSecond Price Monitoring Extn
30th Jan 20239:00 amRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20232:15 pmRNSResults of 2022 Annual General Meeting
19th Jan 20237:00 amRNSQ4 2022 Results and 2023 Outlook
29th Dec 20221:00 pmRNSNotice of AGM
21st Dec 20227:00 amRNSPre-close Q4 2022 – Production Update
21st Dec 20227:00 amRNSFinal Results
19th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.